Page last updated: 2024-08-25

bromopyruvate and Carcinoma, Ehrlich Tumor

bromopyruvate has been researched along with Carcinoma, Ehrlich Tumor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ibrahim, WM; Mansour, MA; Salama, AF; Salama, MM1
Dell'Antone, P1

Other Studies

2 other study(ies) available for bromopyruvate and Carcinoma, Ehrlich Tumor

ArticleYear
Dual inhibition of glycolysis and autophagy as a therapeutic strategy in the treatment of Ehrlich ascites carcinoma.
    Journal of biochemical and molecular toxicology, 2020, Volume: 34, Issue:7

    Topics: Animals; Antineoplastic Agents; Antioxidants; Autophagy; Carcinoma, Ehrlich Tumor; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Female; Glycolysis; Hexokinase; Hydroxychloroquine; Kupffer Cells; Liver; Mice; Mice, Inbred BALB C; Oxidative Stress; Pyruvates

2020
Inactivation of H+-vacuolar ATPase by the energy blocker 3-bromopyruvate, a new antitumour agent.
    Life sciences, 2006, Oct-19, Volume: 79, Issue:21

    Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Energy Metabolism; Enzyme Inhibitors; Hydrogen-Ion Concentration; Liver; Lysosomes; Mice; Pyruvates; Rats; Thymus Gland; Tumor Cells, Cultured; Vacuolar Proton-Translocating ATPases

2006